Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
Clinical trial NCT06795009 · RECRUITING
Trial details
- NCT number
- NCT06795009
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-17
- Primary completion
- 2029-11-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.